178 related articles for article (PubMed ID: 30730551)
1. Interplay between spinal cord and cerebral cortex metabolism in amyotrophic lateral sclerosis.
Marini C; Morbelli S; Cistaro A; Campi C; Caponnetto C; Bauckneht M; Bellini A; Buschiazzo A; Calamia I; Beltrametti MC; Margotti S; Fania P; Poggi I; Cabona C; Capitanio S; Piva R; Calvo A; Moglia C; Canosa A; Massone A; Nobili F; Mancardi G; Chiò A; Piana M; Sambuceti G
Brain; 2018 Aug; 141(8):2272-2279. PubMed ID: 30730551
[TBL] [Abstract][Full Text] [Related]
2. A PET/CT approach to spinal cord metabolism in amyotrophic lateral sclerosis.
Marini C; Cistaro A; Campi C; Calvo A; Caponnetto C; Nobili FM; Fania P; Beltrametti MC; Moglia C; Novi G; Buschiazzo A; Perasso A; Canosa A; Scialò C; Pomposelli E; Massone AM; Bagnara MC; Cammarosano S; Bruzzi P; Morbelli S; Sambuceti G; Mancardi G; Piana M; Chiò A
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2061-71. PubMed ID: 27421971
[TBL] [Abstract][Full Text] [Related]
3. Testing the diagnostic accuracy of [18F]FDG-PET in discriminating spinal- and bulbar-onset amyotrophic lateral sclerosis.
Sala A; Iaccarino L; Fania P; Vanoli EG; Fallanca F; Pagnini C; Cerami C; Calvo A; Canosa A; Pagani M; Chiò A; Cistaro A; Perani D
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1117-1131. PubMed ID: 30617963
[TBL] [Abstract][Full Text] [Related]
4. Brain hypermetabolism in amyotrophic lateral sclerosis: a FDG PET study in ALS of spinal and bulbar onset.
Cistaro A; Valentini MC; Chiò A; Nobili F; Calvo A; Moglia C; Montuschi A; Morbelli S; Salmaso D; Fania P; Carrara G; Pagani M
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):251-9. PubMed ID: 22089661
[TBL] [Abstract][Full Text] [Related]
5. Amyloid- and FDG-PET imaging in amyotrophic lateral sclerosis.
Matías-Guiu JA; Pytel V; Cabrera-Martín MN; Galán L; Valles-Salgado M; Guerrero A; Moreno-Ramos T; Matías-Guiu J; Carreras JL
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):2050-60. PubMed ID: 27262702
[TBL] [Abstract][Full Text] [Related]
6. Brain Stem Glucose Hypermetabolism in Amyotrophic Lateral Sclerosis/Frontotemporal Dementia and Shortened Survival: An
Zanovello M; Sorarù G; Campi C; Anglani M; Spimpolo A; Berti S; Bussè C; Mozzetta S; Cagnin A; Cecchin D
J Nucl Med; 2022 May; 63(5):777-784. PubMed ID: 34503963
[TBL] [Abstract][Full Text] [Related]
7. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis.
Plaitakis A; Constantakakis E; Smith J
Ann Neurol; 1988 Sep; 24(3):446-9. PubMed ID: 2906529
[TBL] [Abstract][Full Text] [Related]
8. Functional pattern of brain FDG-PET in amyotrophic lateral sclerosis.
Pagani M; Chiò A; Valentini MC; Öberg J; Nobili F; Calvo A; Moglia C; Bertuzzo D; Morbelli S; De Carli F; Fania P; Cistaro A
Neurology; 2014 Sep; 83(12):1067-74. PubMed ID: 25122207
[TBL] [Abstract][Full Text] [Related]
9. Combined brain and spinal FDG PET allows differentiation between ALS and ALS mimics.
Van Weehaeghe D; Devrome M; Schramm G; De Vocht J; Deckers W; Baete K; Van Damme P; Koole M; Van Laere K
Eur J Nucl Med Mol Imaging; 2020 Oct; 47(11):2681-2690. PubMed ID: 32314027
[TBL] [Abstract][Full Text] [Related]
10. Value of 18fluorodeoxyglucose-positron-emission tomography in amyotrophic lateral sclerosis: a prospective study.
Van Laere K; Vanhee A; Verschueren J; De Coster L; Driesen A; Dupont P; Robberecht W; Van Damme P
JAMA Neurol; 2014 May; 71(5):553-61. PubMed ID: 24615479
[TBL] [Abstract][Full Text] [Related]
11. Flow-metabolism uncoupling in the cervical spinal cord of ALS patients.
Yamashita T; Hatakeyama T; Sato K; Fukui Y; Hishikawa N; Ohta Y; Nishiyama Y; Kawai N; Tamiya T; Abe K
Neurol Sci; 2017 Apr; 38(4):659-665. PubMed ID: 28120243
[TBL] [Abstract][Full Text] [Related]
12. Brain metabolic correlates of apathy in amyotrophic lateral sclerosis: An 18F-FDG-positron emission tomography stud.
Canosa A; Vacchiano V; D'Ovidio F; Calvo A; Moglia C; Manera U; Vasta R; Liguori R; Arena V; Grassano M; Palumbo F; Peotta L; Iazzolino B; Pagani M; Chiò A
Eur J Neurol; 2021 Mar; 28(3):745-753. PubMed ID: 33175462
[TBL] [Abstract][Full Text] [Related]
13. Spinal cord hypermetabolism extends to skeletal muscle in amyotrophic lateral sclerosis: a computational approach to [18F]-fluorodeoxyglucose PET/CT images.
Bauckneht M; Lai R; Miceli A; Schenone D; Cossu V; Donegani MI; Raffa S; Borra A; Marra S; Campi C; Orengo A; Massone AM; Tagliafico A; Caponnetto C; Cabona C; Cistaro A; Chiò A; Morbelli S; Nobili F; Sambuceti G; Piana M; Marini C
EJNMMI Res; 2020 Mar; 10(1):23. PubMed ID: 32201914
[TBL] [Abstract][Full Text] [Related]
14. Prospective Validation of 18F-FDG Brain PET Discriminant Analysis Methods in the Diagnosis of Amyotrophic Lateral Sclerosis.
Van Weehaeghe D; Ceccarini J; Delva A; Robberecht W; Van Damme P; Van Laere K
J Nucl Med; 2016 Aug; 57(8):1238-43. PubMed ID: 26940764
[TBL] [Abstract][Full Text] [Related]
15. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis.
Rothstein JD; Martin LJ; Kuncl RW
N Engl J Med; 1992 May; 326(22):1464-8. PubMed ID: 1349424
[TBL] [Abstract][Full Text] [Related]
16. FDG-PET shows weak correlation between focal motor weakness and brain metabolic alterations in ALS.
Sennfält S; Pagani M; Fang F; Savitcheva I; Estenberg U; Ingre C
Amyotroph Lateral Scler Frontotemporal Degener; 2023 Aug; 24(5-6):485-494. PubMed ID: 36755485
[No Abstract] [Full Text] [Related]
17. Lack of change in indoleamine metabolism in spinal cord of patients with amyotrophic lateral sclerosis.
Ohsugi K; Adachi K; Mukoyama M; Ando K
Neurosci Lett; 1987 Aug; 79(3):351-4. PubMed ID: 2443876
[TBL] [Abstract][Full Text] [Related]
18. Multicenter validation of [
D'hulst L; Van Weehaeghe D; Chiò A; Calvo A; Moglia C; Canosa A; Cistaro A; Willekens SM; De Vocht J; Van Damme P; Pagani M; Van Laere K
Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):570-577. PubMed ID: 29862846
[TBL] [Abstract][Full Text] [Related]
19. Class I and II histone deacetylase expression is not altered in human amyotrophic lateral sclerosis: Neuropathological and positron emission tomography molecular neuroimaging evidence.
Dios AM; Babu S; Granucci EJ; Mueller KA; Mills AN; Alshikho MJ; Zürcher NR; Cernasov P; Gilbert TM; Glass JD; Berry JD; Atassi N; Hooker JM; Sadri-Vakili G
Muscle Nerve; 2019 Oct; 60(4):443-452. PubMed ID: 31241177
[TBL] [Abstract][Full Text] [Related]
20. Lowered cerebral glucose utilization in amyotrophic lateral sclerosis.
Dalakas MC; Hatazawa J; Brooks RA; Di Chiro G
Ann Neurol; 1987 Nov; 22(5):580-6. PubMed ID: 3501273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
